Your browser is no longer supported. Please, upgrade your browser.
Settings
AGN Allergan plc daily Stock Chart
AGN [NYSE]
Allergan plc
IndexS&P 500 P/E- EPS (ttm)-25.60 Insider Own0.10% Shs Outstand328.45M Perf Week1.96%
Market Cap54.38B Forward P/E9.79 EPS next Y16.91 Insider Trans0.00% Shs Float327.14M Perf Month5.90%
Income-8519.10M PEG- EPS next Q4.20 Inst Own90.30% Short Float2.22% Perf Quarter43.06%
Sales15.68B P/S3.47 EPS this Y24.90% Inst Trans2.46% Short Ratio1.45 Perf Half Y9.76%
Book/sh182.05 P/B0.91 EPS next Y1.23% ROA-8.50% Target Price180.13 Perf Year-12.90%
Cash/sh6.01 P/C27.55 EPS next 5Y3.27% ROE-13.20% 52W Range114.27 - 197.00 Perf YTD23.87%
Dividend2.96 P/FCF12.61 EPS past 5Y-36.00% ROI-4.80% 52W High-15.96% Beta1.65
Dividend %1.79% Quick Ratio0.90 Sales past 5Y43.40% Gross Margin85.10% 52W Low44.88% ATR1.79
Employees16900 Current Ratio1.00 Sales Q/Q-0.80% Oper. Margin-54.60% RSI (14)64.48 Volatility1.03% 1.06%
OptionableYes Debt/Eq0.38 EPS Q/Q-285.10% Profit Margin-54.20% Rel Volume0.39 Prev Close166.14
ShortableYes LT Debt/Eq0.33 EarningsAug 06 BMO Payout- Avg Volume5.01M Price165.56
Recom2.70 SMA202.52% SMA502.36% SMA20012.19% Volume1,953,314 Change-0.35%
Aug-07-19Downgrade Guggenheim Buy → Neutral
Jul-18-19Downgrade SVB Leerink Outperform → Mkt Perform
Jul-16-19Downgrade Bernstein Outperform → Mkt Perform
Jun-11-19Initiated Barclays Underweight $133
May-28-19Initiated Goldman Neutral
Apr-15-19Initiated Jefferies Hold
Mar-20-19Initiated SunTrust Buy $178
Jan-31-19Downgrade Credit Suisse Outperform → Neutral
Jan-30-19Downgrade RBC Capital Mkts Outperform → Sector Perform
Jan-30-19Downgrade Morgan Stanley Overweight → Equal-Weight
Oct-09-18Resumed Guggenheim Buy
Apr-24-18Resumed Citigroup Buy $200
Apr-23-18Resumed Evercore ISI Outperform
Apr-17-18Initiated Stifel Hold $192
Feb-23-18Initiated SunTrust Buy $200
Feb-07-18Reiterated Leerink Partners Outperform $237 → $242
Dec-07-17Downgrade Argus Buy → Hold
Nov-29-17Upgrade Morgan Stanley Equal-Weight → Overweight
Nov-27-17Resumed Leerink Partners Outperform $237
Nov-02-17Reiterated RBC Capital Mkts Outperform $250 → $221
Sep-16-19 05:50PM  Allergan (AGN) Dips More Than Broader Markets: What You Should Know Zacks
09:01AM  AbbVie Inc. -- Moody's assigns Baa2 to AbbVie's euro notes; stable outlook Moody's
Sep-13-19 11:08AM  Ardelyx Gets FDA Approval for Ibsrela As IBS-C Treatment Zacks
09:46AM  Pharma Stock Roundup: Pipeline/Regulatory Updates From GSK, PFE & Others Zacks
Sep-12-19 07:25PM  Seth Klarman's Favorite Health Care Stocks GuruFocus.com
06:22PM  Consumer groups, unions urge caution on $63 billion AbbVie deal for Allergan Reuters
06:11PM  Consumer groups, unions urge caution on $63 bln AbbVie deal for Allergan Reuters
04:09PM  Humira Sales Will Crash To $3 Billion Why AbbVie Stock Got An Upgrade Investor's Business Daily
11:47AM  Buy AbbVie Stock, Because Its Deal for Allergan Just Might Work, Analyst Says Barrons.com
Sep-11-19 06:01AM  Allergan's Filings for Abicipar Pegol Accepted in U.S/Europe Zacks
Sep-10-19 05:45PM  Allergan (AGN) Outpaces Stock Market Gains: What You Should Know Zacks
04:36PM  Allergan Shareholder Meetings Scheduled for October 14, 2019 PR Newswire
Sep-09-19 11:33AM  The Zacks Analyst Blog Highlights: Allergan, Merck, Roche, J&J and Bristol-Myers Zacks
09:19AM  U.S. judge denies bid to dismiss claim opioids are a public nuisance Reuters
07:30AM  Allergan and Molecular Partners Announce Acceptance of U.S. FDA Biologics License Application and Validation of EMA Marketing Authorisation for Abicipar pegol in Patients with Neovascular (Wet) Age-related Macular Degeneration PR Newswire
Sep-06-19 03:07PM  ETFs Poised to Benefit from Gene Editing Revolution Zacks
01:29PM  UPDATE 1-Mallinckrodt to pay $24 mln in cash to settle opioid lawsuits with two Ohio counties Reuters
11:36AM  Pharma Stock Roundup: AGN's Opioid Settlement, Line Extension Nod in EU for MRK, JNJ Drugs Zacks
Sep-05-19 04:51PM  3 Special Situations Gurus Are Buying GuruFocus.com
10:35AM  Endo Gains FDA Nod for Orfadin Generic to Treat Rare Disease Zacks
09:31AM  Allergan (AGN) Up 1.8% Since Last Earnings Report: Can It Continue? Zacks
03:10AM  [video]Mallinckrodt Plunges on Report It's Considering Filing for Bankruptcy TheStreet.com
Sep-04-19 05:50PM  Allergan (AGN) Outpaces Stock Market Gains: What You Should Know Zacks
04:22PM  Why The Opioid Epidemic Just Got More Complicated For Generic Pharmas Investor's Business Daily
10:31AM  Ardelyx (ARDX) Gains on Tenapanor's Success in Pivotal Study Zacks
10:00AM  AbbVie Stock Is Poised To Become A Top 5 Pharma But Should You Buy It? Investor's Business Daily
Sep-03-19 07:30AM  Allergan Receives FDA Approval of Juvéderm VOLUMA® XC For Mid-Face Injection Via Cannula PR Newswire
Sep-02-19 09:41AM  Allergan Settles Ahead of Multi-District Opioid Litigation Zacks
Aug-30-19 10:03AM  Allergan Settles to Get Out Of First Big Opioid Trial Barrons.com
09:57AM  Its Not All Bad News for Generic-Drug Companies. Sales Rose in July. Barrons.com
08:00AM  Will Opioid Litigation Take its Toll on Pharma Companies? Zacks
07:09AM  Allergan settles with 2 Ohio plaintiffs in federal opioid litigation MarketWatch
07:00AM  Allergan Announces Settlement with Two Ohio Plaintiffs in Federal Opioid Litigation PR Newswire
05:39AM  [video]Allergan Reaches Settlement With Ohio Plaintiffs in Federal Opioid Litigation TheStreet.com
Aug-28-19 04:29PM  What Purdue's Rumored Deal Means For Other Opioid-Tied Pharmas Investor's Business Daily
Aug-27-19 02:03PM  Should You Buy AbbVie for the Dividend? Motley Fool
11:01AM  J&J Up Despite $572M Fine in Oklahoma Opioid Abuse Case Zacks
Aug-23-19 10:36AM  Amgen Presents Positive Data From Rituxan Biosimilar Study Zacks
10:15AM  J&J's (JNJ) Opioid Lawsuit Verdict in Oklahoma Due Next Week Zacks
04:59AM  Hedge Funds Pile Into Health Care Investopedia
Aug-22-19 09:00AM  Amgen And Allergan Announce Positive Top-Line Results From Comparative Clinical Study Of ABP 798, Biosimilar Candidate To Rituxan® (Rituximab) PR Newswire
Aug-21-19 04:15PM  Opioid Epidemic: Will Pharmas Scramble To Settle As Landmark Case Looms? Investor's Business Daily
01:38PM  Endo Up on Settlement of a Few Cases Related to Opioid Drugs Zacks
01:11PM  Goldman Warns Hedge Fund Outperformance Holds Crowding Risk Bloomberg
07:15AM  AbbVie Stock Slipped to a New Low, and One Exec Scooped Up Shares Barrons.com
Aug-20-19 12:20PM  Endo, Allergan could avoid trial with opioid settlements Yahoo Finance Video
11:06AM  Buy AbbVie Stock Because You Cant Ignore How Cheap It Is Barrons.com
10:15AM  Endo, Allergan could avoid trial with Ohio over opioid crisis Yahoo Finance Video
09:44AM  Here's Why Allergan is Outperforming Its Industry Of Late Zacks
06:43AM  Endo Surges as Opioid Maker Reaches Settlement in Landmark Lawsuit TheStreet.com
03:23AM  [video]Endo, Allergan Nearing Deals to Limit Ohio Litigation Over Opioids - Report TheStreet.com
Aug-19-19 02:45PM  Obesity Epidemic Leads To A New Problem And It Could Be Worth Billions Investor's Business Daily
Aug-15-19 12:50PM  Seth Klarman's Baupost Boosts Liberty, Reduces eBay GuruFocus.com
Aug-14-19 07:59AM  Correction: Allergan sale Financial Times
12:00AM  Elliott bags Goldmans Barg Financial Times
Aug-13-19 10:59AM  Implied Volatility Surging for Allergan (AGN) Stock Options Zacks
10:48AM  Here's Why Amgen Stock is Outperforming Its Industry Of Late Zacks
09:45AM  Can Value Investors Consider Allergan (AGN) a Worthy Pick? Zacks
01:04AM  JPMorgan Chase set to scoop record fee for Allergan sale Financial Times
Aug-12-19 07:59AM  UPDATE 1-Evolus reports sales of its Botox rival ahead of expectations Reuters
07:01AM  Evolus says launch of its Botox rival ahead of its expectations Reuters
Aug-09-19 09:50AM  Pharma Stock Roundup: AGN, NVO Earnings, EU Nod to SNY & ABBV Drugs for New Patients Zacks
Aug-08-19 08:34AM  Teva (TEVA) Q2 Earnings, Sales Top Estimates, CFO Steps Down Zacks
Aug-07-19 09:32AM  Editas (EDIT) Misses on Q2 Earnings & Sales, Gets New CEO Zacks
Aug-06-19 03:00PM  Allergan Boosts 2019 Guidance While Waiting to be Acquired by AbbVie Motley Fool
01:19PM  Allergan beats second-quarter expectations, boosts full-year guidance MarketWatch
10:19AM  Allergan (AGN) Q2 Earnings & Sales Top, '19 Sales View Up Zacks
10:16AM  Company News For Aug 6, 2019 Zacks
09:58AM  Allergan beats profit, raises revenue forecast on Restasis, Juvederm demand Reuters
09:51AM  Allergan beats profit, raises revenue forecast on Restasis, Juvederm demand Reuters
08:55AM  Allergan (AGN) Surpasses Q2 Earnings and Revenue Estimates Zacks
07:32AM  Allergan Reports Q2 Earnings Beat, Reaffirms Guidance Benzinga
07:26AM  Allergan reports second-quarter earnings beat MarketWatch
07:00AM  Allergan Reports Second Quarter 2019 Financial Results PR Newswire
05:37AM  Allergan Tops Q2 Profit Estimate, Lifts 2019 Revenue Guidance After Abbive Deal TheStreet.com
Aug-05-19 10:10AM  Can Allergan (AGN) Keep the Earnings Surprise Streak Alive? Zacks
10:09AM  Is a Beat in Store for Melinta (MLNT) This Earnings Season? Zacks
09:07AM  Will Cost Control Help Teva (TEVA) Beat on Q2 Earnings? Zacks
Aug-02-19 05:45PM  Allergan (AGN) Gains As Market Dips: What You Should Know Zacks
07:30AM  Allergan to Report Second Quarter 2019 Financial Results PR Newswire
Aug-01-19 09:21AM  Proteostasis (PTI) to Post Q2 Earnings: What's in Store? Zacks
Jul-31-19 10:58AM  Ironwood (IRWD) Q2 Earnings and Revenues Beat Estimates Zacks
08:35AM  Should You Buy Allergan (AGN) Ahead of Earnings? Zacks
05:01AM  Heres How Pfizer Stock (and Pharma) Stand to Benefit From Mylan Deal InvestorPlace
Jul-30-19 12:58PM  T. Rowe Price Buys Fox, General Electric GuruFocus.com
Jul-29-19 11:08AM  Guardant Health (GH) to Report Q2 Earnings: What's in Store? Zacks
07:30AM  Ashley Tisdale Joins The Allergan 'Women Who Know' Campaign PR Newswire
Jul-26-19 06:23PM  AbbVie Inc (ABBV) Q2 2019 Earnings Call Transcript Motley Fool
11:51AM  AbbVie spotlights Allergan deal, new drugs as Humira sales wane Reuters
11:50AM  What's in the Cards for Amarin (AMRN) This Earnings Season? Zacks
10:15AM  AbbVie does not expect to divest new psoriasis drug Reuters
09:27AM  5 Drug/Biotech Stocks Set to Beat Earnings Estimates in Q2 Zacks
08:52AM  AbbVie Delivers a Win on Earnings and Raises Profit Forecast Barrons.com
Jul-25-19 09:00AM  Allergan and Editas Medicine Initiate the Brilliance Phase 1/2 Clinical Trial of AGN-151587 (EDIT-101) for the Treatment of LCA10 GlobeNewswire
07:29AM  What's in the Cards for AcelRx (ACRX) This Earnings Season? Zacks
Jul-24-19 05:48PM  Allergan issues worldwide recall for textured breast implants ABC News Videos
11:26AM  Allergan recalls textured breast implants worldwide Reuters
09:16AM  UPDATE 3-Allergan recalls textured breast implants worldwide Reuters
08:59AM  Allergan issues worldwide recall of Biocell textured implants and tissue expanders MarketWatch
08:55AM  Allergan Voluntarily Recalls BIOCELL® Textured Breast Implants and Tissue Expanders PR Newswire
Allergan plc, a pharmaceutical company, develops, manufactures, and commercializes branded pharmaceutical, device, biologic, surgical, and regenerative medicine products worldwide. The company operates in three segments: US Specialized Therapeutics, US General Medicine, and International. It offers a portfolio of products in various therapeutic areas, including medical aesthetics and dermatology, eye care, neuroscience, urology, gastrointestinal, women's health, and anti-infective therapeutic products. The company also offers breast implants and tissue expanders; and RM-131 (relamorelin), a peptide ghrelin agonist for the treatment of diabetic gastroparesis. In addition, it develops medical and cosmetic treatments; therapies for non-alcoholic steatohepatitis and other liver diseases; inhibitor for the treatment of psoriasis and other autoimmune disorders; atopic dermatitis drug candidate; peri-ocular rings for extended drug delivery and reducing elevated intraocular pressure in glaucoma patients; and treatments for neurodegenerative disorders, including Alzheimer's disease. Further, the company develops RST-001, a novel gene therapy for the treatment of retinitis pigmentosa; small molecule therapeutics for inflammatory and fibrotic diseases; topical medicines for fat reduction; and delivery system and botulinum toxin-based prescription products. It has a collaboration, option, and license agreement with Lyndra, Inc.; strategic alliance and option agreement with Editas Medicine, Inc.; and gene therapy research collaboration with The National Institute for Bioprocessing Research and Training. Allergan plc also has licensing agreements with Assembly Biosciences, Inc.; MedImmune; and Heptares Therapeutics, Ltd. The company was formerly known as Actavis plc and changed its name to Allergan plc in June 2015. Allergan plc was founded in 1983 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SAUNDERS BRENT LChairman, President and CEOMar 07Buy143.671,760252,858170,666Mar 07 03:19 PM
WALSH MATTHEW MEVP, Chief Financial OfficerNov 16Buy157.001,000157,00026,416Nov 19 07:22 PM